Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Carcinoma

Explore clinical trials studying Metastatic Breast Carcinoma. Study availability and eligibility vary by location and protocol.

56 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Carcinoma trial results

Active, Not Recruiting

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

NCT02115282

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Adenocarcinoma, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Mercy San Juan Medical Center Carmichael, California, United States
  • Enloe Medical Center Chico, California, United States
View all 654 locations
View Trial Details
Active, Not Recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494

Conditions
Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
Locations
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

NCT06557148

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma, +15 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All protocol activity) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

NCT01463072

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Carcinoma, +11 more
Locations
  • City of Hope medical Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

NCT04316117

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT01351909

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Unresectable Breast Carcinoma, +9 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

NCT03281902

Conditions
Advanced Breast Carcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

NCT03737695

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions